BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paliperidone palmitate (CSPC) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Paliperidone palmitate (CSPC)\, from Clin
 icalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07493551-9274@assetmemo.bio
DTSTAMP:20261121T005923Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Paliperidone palmitate (CSPC): Phase na readout est. (NCT07493551)
DESCRIPTION:Paliperidone palmitate (CSPC)\, phase na\, Schizophrenia.\nStud
 y: A Bioequivalence Study of PP3M in Patients With Schizophrenia\nEstimate
 d primary completion: 31 December 2026. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/paliperidone-palmitate-cspc#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07493551
URL:https://assetmemo.bio/drug/paliperidone-palmitate-cspc#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
